Original language | English (US) |
---|---|
Pages (from-to) | 396-397 |
Number of pages | 2 |
Journal | Biological psychiatry |
Volume | 74 |
Issue number | 6 |
DOIs |
|
State | Published - Sep 15 2013 |
Funding
Dr. Cronenwett has received research funding from Novartis Inc., Sunovion Pharmaceuticals Inc., Otsuka Pharmaceuticals Inc., and Naurex Inc. Dr. Csernansky has received consulting fees for service on a data monitoring committee for Eli Lilly and Co.
ASJC Scopus subject areas
- Biological Psychiatry